Disease network delineates the disease progression profile of cardiovascular diseases.


Journal

Journal of biomedical informatics
ISSN: 1532-0480
Titre abrégé: J Biomed Inform
Pays: United States
ID NLM: 100970413

Informations de publication

Date de publication:
03 2021
Historique:
received: 29 10 2020
revised: 14 01 2021
accepted: 15 01 2021
pubmed: 26 1 2021
medline: 29 7 2021
entrez: 25 1 2021
Statut: ppublish

Résumé

As Electronic Health Records (EHR) data accumulated explosively in recent years, the tremendous amount of patient clinical data provided opportunities to discover real world evidence. In this study, a graphical disease network, named progressive cardiovascular disease network (progCDN), was built to delineate the progression profiles of cardiovascular diseases (CVD). The EHR data of 14.3 million patients with CVD diagnoses were collected for building disease network and further analysis. We applied a new designed method, progression rates (PR), to calculate the progression relationship among different diagnoses. Based on the disease network outcome, 23 disease progression pair were selected to screen for salient features. The network depicted the dominant diseases in CVD development, such as the heart failure and coronary arteriosclerosis. Novel progression relationships were also discovered, such as the progression path from long QT syndrome to major depression. In addition, three age-group progCDNs identified a series of age-associated disease progression paths and important successor diseases with age bias. Furthermore, a list of important features with sufficient abundance and high correlation was extracted for building disease risk models. The PR method designed for identifying the progression relationship could be widely applied in any EHR database due to its flexibility and robust functionality. Meanwhile, researchers could use the progCDN network to validate or explore novel disease relationships in real world data. The first-time interrogation of such a huge CVD patients cohort enabled us to explore the general and age-specific disease progression patterns in CVD development.

Identifiants

pubmed: 33493631
pii: S1532-0464(21)00015-0
doi: 10.1016/j.jbi.2021.103686
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103686

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Zefang Tang (Z)

IBM Research, Beijing, China. Electronic address: monkeytzf@gmail.com.

Yiqin Yu (Y)

IBM Research, Beijing, China.

Kenney Ng (K)

Center for Computational Health, IBM Research, Yorktown Heights, NY, USA.

Daby Sow (D)

Center for Computational Health, IBM Research, Yorktown Heights, NY, USA.

Jianying Hu (J)

Center for Computational Health, IBM Research, Yorktown Heights, NY, USA.

Jing Mei (J)

IBM Research, Beijing, China. Electronic address: meijing@cn.ibm.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH